Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective studyKazuhiro Takahashi, Takahiro Kimura, Jun Miki et al.|Japanese Journal of Clinical Oncology|2023Cited by 13
Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinomaWataru Fukuokaya, Shin Egawa, Takahiro Kimura et al.|Cancer Immunology Immunotherapy|2021Cited by 11
Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort studyHirokazu Kagawa, Fumihiko Urabe, Yuria Kiuchi et al.|International Journal of Clinical Oncology|2023Cited by 10
Prospective comparison of the efficacy of caudal versus periprostatic nerve block, both with intrarectal local anesthesia, during transrectal ultrasonography-guided prostatic needle biopsyFumihiko Urabe, Shin Egawa, Takahiro Kimura et al.|Scandinavian Journal of Urology|2017Cited by 10
Prognostic significance of subclassifying pathological <scp>T3</scp> upper tract urothelial carcinoma: Results from a multicenter cohort studyYushi Suhara, Fumihiko Urabe, Kentaro Yoshihara et al.|International Journal of Urology|2023Cited by 8